110 related articles for article (PubMed ID: 3899472)
1. Multicenter evaluation of six methods for predicting warfarin maintenance-dose requirements from initial response.
Sawyer WT; Poe TE; Canaday BR; Weiner JS; Williams DM; Webb CE; Ellison MJ
Clin Pharm; 1985; 4(4):440-6. PubMed ID: 3899472
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of three dosage-prediction methods for initial in-hospital stabilization of warfarin therapy.
Carter BL; Taylor JW; Becker A
Clin Pharm; 1987 Jan; 6(1):37-45. PubMed ID: 3816105
[TBL] [Abstract][Full Text] [Related]
3. Predicting warfarin maintenance dosage based on initial response.
Miller DR; Brown MA
Am J Hosp Pharm; 1979 Oct; 36(10):1351-5. PubMed ID: 507078
[TBL] [Abstract][Full Text] [Related]
4. Effect of using warfarin plasma concentrations in Bayesian forecasting of prothrombin-time response.
Lee C; Coleman RW; Mungall DR
Clin Pharm; 1987 May; 6(5):406-12. PubMed ID: 3665392
[TBL] [Abstract][Full Text] [Related]
5. The negative impact of biological variation in the effect and clearance of warfarin on methods for prediction of dose requirements.
Weiss P; Halkin H; Almog S
Thromb Haemost; 1986 Dec; 56(3):371-5. PubMed ID: 3563968
[TBL] [Abstract][Full Text] [Related]
6. Initiation of warfarin therapy in elderly medical inpatients: a safe and accurate regimen.
Siguret V; Gouin I; Debray M; Perret-Guillaume C; Boddaert J; Mahé I; Donval V; Seux ML; Romain-Pilotaz M; Gisselbrecht M; Verny M; Pautas E
Am J Med; 2005 Feb; 118(2):137-42. PubMed ID: 15694897
[TBL] [Abstract][Full Text] [Related]
7. Warfarin dosage predictions assisted by the analog computer.
Carter BL; Barr W; Rock W; Taylor JW
Ther Drug Monit; 1988; 10(1):69-73. PubMed ID: 3376184
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a pharmacy-managed warfarin-monitoring service to coordinate inpatient and outpatient therapy.
Ellis RF; Stephens MA; Sharp GB
Am J Hosp Pharm; 1992 Feb; 49(2):387-94. PubMed ID: 1554003
[TBL] [Abstract][Full Text] [Related]
9. Single-dose fluconazole for vulvovaginal candidiasis: impact on prothrombin time in women taking warfarin.
Turrentine MA
Obstet Gynecol; 2006 Feb; 107(2 Pt 1):310-3. PubMed ID: 16449117
[TBL] [Abstract][Full Text] [Related]
10. Warfarin maintenance dose adjustment with indirect pharmacodynamic model in rats.
Cao YG; Liu XQ; Chen YC; Hao K; Wang GJ
Eur J Pharm Sci; 2007 Feb; 30(2):175-80. PubMed ID: 17169538
[TBL] [Abstract][Full Text] [Related]
11. Low-dose fluconazole therapy potentiates the hypoprothrombinemic response of warfarin sodium.
Crussell-Porter LL; Rindone JP; Ford MA; Jaskar DW
Arch Intern Med; 1993 Jan; 153(1):102-4. PubMed ID: 8422191
[TBL] [Abstract][Full Text] [Related]
12. Optimal initial dose adjustment of warfarin in orthopedic patients.
Lenzini PA; Grice GR; Milligan PE; Gatchel SK; Deych E; Eby CS; Burnett RS; Clohisy JC; Barrack RL; Gage BF
Ann Pharmacother; 2007 Nov; 41(11):1798-804. PubMed ID: 17911206
[TBL] [Abstract][Full Text] [Related]
13. Assessment of patient capability to self-adjust oral anticoagulant dose: a multicenter study on home use of portable prothrombin time monitor (COAGUCHECK).
Cosmi B; Palareti G; Carpanedo M; Pengo V; Biasiolo A; Rampazzo P; Morstabilini G; Testa S
Haematologica; 2000 Aug; 85(8):826-31. PubMed ID: 10942929
[TBL] [Abstract][Full Text] [Related]
14. Predicting the dose of warfarin for therapeutic anticoagulation.
Sharma NK; Routledge PA; Rawlins MD; Davies DM
Thromb Haemost; 1982 Jun; 47(3):230-1. PubMed ID: 7112495
[TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
16. Antidotal effect of vitamin K1 against warfarin-induced anticoagulation in horses.
Byars TD; Greene CE; Kemp DT
Am J Vet Res; 1986 Oct; 47(10):2309-12. PubMed ID: 3777660
[TBL] [Abstract][Full Text] [Related]
17. Outpatient management of warfarin therapy: comparison of computer-predicted dosage adjustment to skilled professional care.
White RH; Mungall D
Ther Drug Monit; 1991 Jan; 13(1):46-50. PubMed ID: 2057991
[TBL] [Abstract][Full Text] [Related]
18. Mitral valve replacement with St. Jude Medical prosthesis and low-dose anticoagulation in patients aged over 50 years.
Katircioglu SF; Yamak B; Ulus AT; Tasdemir O; Bayazit K
J Heart Valve Dis; 1998 Jul; 7(4):455-9. PubMed ID: 9697071
[TBL] [Abstract][Full Text] [Related]
19. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis.
Levine MN; Hirsh J; Gent M; Turpie AG; Weitz J; Ginsberg J; Geerts W; LeClerc J; Neemeh J; Powers P
Thromb Haemost; 1995 Aug; 74(2):606-11. PubMed ID: 8584992
[TBL] [Abstract][Full Text] [Related]
20. Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis.
Yamak B; Iscan Z; Mavitas B; Ulus AT; Katircioglu SF; Tasdemir O; Bayazit K
J Heart Valve Dis; 1999 Nov; 8(6):665-73. PubMed ID: 10616246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
